SCHOTT Pharma AG & Co KgaA banner

SCHOTT Pharma AG & Co KgaA
F:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
F:1SXP
Watchlist
Price: 14.02 EUR -1.13%
Market Cap: €2.1B

Gross Margin

33.7%
Current
Declining
by 0.4%
vs 3-y average of 34.1%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
33.7%
=
Gross Profit
€332.5m
/
Revenue
€986.2m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
33.7%
=
Gross Profit
€332.5m
/
Revenue
€986.2m

Peer Comparison

Country Company Market Cap Gross
Margin
DE
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
2.1B EUR
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
204.8B USD
Loading...
US
Danaher Corp
NYSE:DHR
152.3B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
75.9T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
35.6B CHF
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
280B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
37B USD
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
30.6B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.3B USD
Loading...
US
Waters Corp
NYSE:WAT
22.6B USD
Loading...

Market Distribution

In line with most companies in Germany
Percentile
35th
Based on 3 457 companies
35th percentile
33.7%
Low
-5 776.5% — 29.1%
Typical Range
29.1% — 60.9%
High
60.9% — 184.7%
Distribution Statistics
Germany
Min -5 776.5%
30th Percentile 29.1%
Median 44.6%
70th Percentile 60.9%
Max 184.7%

SCHOTT Pharma AG & Co KgaA
Glance View

SCHOTT Pharma AG & Co KgaA, carved from the renowned SCHOTT AG, stands as a beacon in the pharmaceutical packaging industry. With roots deeply embedded in scientific glass manufacturing, SCHOTT Pharma specializes in providing sophisticated solutions for the containment and delivery of medicines. Their core expertise revolves around the development and production of high-quality glass and polymer products, including pre-fillable syringes, vials, and cartridges. These products are meticulously crafted to meet the stringent safety and quality demands of the healthcare sector, ensuring optimal preservation and delivery of pharmaceutical substances. The company leverages its profound understanding of material science, coupled with a focus on innovation, to offer tailored solutions to pharmaceutical companies across the globe. SCHOTT Pharma's business model thrives on collaboration and partnership with its clients, ensuring their specific needs are met with precision. The firm earns its revenue by forging long-term relationships with leading pharmaceutical players, supplying them with specialized containers designed to enhance drug stability and extend shelf life. This relationship is symbiotic, as SCHOTT Pharma not only provides the physical packaging but also lends its expertise in regulatory compliance and product testing, thereby positioning itself as a crucial contributor to its clients' overall success. By investing deeply in research and development, SCHOTT Pharma continues to innovate, maintaining its competitive edge and ensuring consistent demand for its high-performance pharmaceutical packaging solutions.

1SXP Intrinsic Value
28.78 EUR
Undervaluation 51%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
33.7%
=
Gross Profit
€332.5m
/
Revenue
€986.2m
What is SCHOTT Pharma AG & Co KgaA's current Gross Margin?

The current Gross Margin for SCHOTT Pharma AG & Co KgaA is 33.7%, which is below its 3-year median of 34.1%.

How has Gross Margin changed over time?

Over the last 2 years, SCHOTT Pharma AG & Co KgaA’s Gross Margin has decreased from 35.2% to 33.7%. During this period, it reached a low of 32.9% on Mar 31, 2025 and a high of 35.4% on Dec 31, 2023.

Back to Top